List of Contents

Platelet Rich Plasma Market Size, Share, and Trends 2025 to 2034

The global platelet rich plasma market size is estimated at USD 962.46 million in 2025 and is predicted to reach around USD 3,466.13 million by 2034, accelerating at a CAGR of 15.30% from 2025 to 2034. The North America platelet rich plasma market size surpassed USD 367.29 million in 2024 and is expanding at a CAGR of 15.43% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : June 2025
  • Report Code : 1237
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Platelet Rich Plasma Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Platelet Rich Plasma Market

5.1. Covid-19: Platelet Rich Plasma Industry Impact

5.2. Platelet Rich Plasma Business Impact Assessment: Covid-19

5.2.1. Services Challenges/Disruption

5.2.2. Market Trends and Platelet Rich Plasma Opportunities in the COVID-19 Landscape for Major Markets

5.3. Strategic Measures against Covid-19

5.3.1. Government Support and Initiative to Combat Covid-19

5.3.2. Proposal for Platelet Rich Plasma Market Players to deal with Covid-19 Pandemic Scenario

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.1.1. Intensifying elderly population and mounting pervasiveness of orthopedic situtaions

6.1.1.2. Growing applications of platelet-rich plasma products in hair transplant and other cosmetic applications

6.1.2. Market Restraints

6.1.2.1. Restraint 1

6.1.3. Market Opportunities

6.1.3.1. Opportunity 1

6.1.3.2. Opportunity 2

Chapter 7. Global Platelet Rich Plasma Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.1.1. Platelet Rich Plasma Market Revenue by Market Players

7.1.1.2. Platelet Rich Plasma Market Revenue Market Share by Market Players

7.1.2. Key Organic/Inorganic Strategies Adopted by Players

7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation

7.1.2.2. Merger and Acquisition, Collaboration and Partnerships

7.1.3. Market Players Landscape

7.1.3.1. List of Product Type Suppliers

7.1.3.2. List of End-users

Chapter 8. Global Platelet Rich Plasma Market, By Product Type

8.1. Platelet Rich Plasma Market, by Component

8.1.1. Leukocyte Rich PRP

8.1.1.1. Market Revenue and Forecast

8.1.2. Pure PRP

8.1.2.1. Market Revenue and Forecast

8.1.3. Leukocyte Rich Fibrin

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Platelet Rich Plasma Market, By Application

9.1. Platelet Rich Plasma Market, by Application

9.1.1. Allogeneic PRP

9.1.1.1. Market Revenue and Forecast

9.1.2. Autologous PRP

9.1.2.1. Market Revenue and Forecast

9.1.3. Homologous PRP

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Platelet Rich Plasma Market, By End-user

10.1. Platelet Rich Plasma Market, by End-user

10.1.1. Cosmetic Surgery & Dermatology

10.1.1.1. Market Revenue and Forecast

10.1.2. Orthopedic Surgery

10.1.2.1. Market Revenue and Forecast

10.1.3. General Surgery

10.1.3.1. Market Revenue and Forecast

10.1.4. Ophthalmic Surgery

10.1.4.1. Market Revenue and Forecast

10.1.5. Neurosurgery

10.1.5.1. Market Revenue and Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Platelet Rich Plasma Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue Forecast by Product Type

11.1.2. Market Revenue Forecast by Application

11.1.3. Market Revenue Forecast by End-user

11.1.4. U.S

11.1.4.1. Market Revenue Forecast

11.1.5. Canada

11.1.5.1. Market Revenue Forecast

11.2. Europe

11.2.1. Market Revenue Forecast by Product Type

11.2.2. Market Revenue Forecast by Application

11.2.3. Market Revenue Forecast by End-user

11.2.4. UK

11.2.4.1. Market Revenue Forecast

11.2.5. Germany

11.2.5.1. Market Revenue Forecast

11.2.6. France

11.2.6.1. Market Revenue Forecast

11.2.7. Rest of EU

11.2.7.1. Market Revenue Forecast

11.3. Asia Pacific (APAC)

11.3.1. Market Revenue Forecast by Product Type

11.3.2. Market Revenue Forecast by Application

11.3.3. Market Revenue Forecast by End-user

11.3.4. China

11.3.4.1. Market Revenue Forecast

11.3.5. India

11.3.5.1. Market Revenue Forecast

11.3.6. Japan

11.3.6.1. Market Revenue Forecast

11.3.7. Rest of APAC

11.3.7.1. Market Revenue Forecast

11.4. LATAM

11.4.1. Market Revenue Forecast by Product Type

11.4.2. Market Revenue Forecast by Application

11.4.3. Market Revenue Forecast by End-user

11.4.4. Brazil

11.4.4.1. Market Revenue Forecast

11.4.5. Rest of LATAM

11.4.5.1. Market Revenue Forecast

11.5. Middle East and Africa (MEA)

11.5.1. Market Revenue Forecast by Product Type

11.5.2. Market Revenue Forecast by Application

11.5.3. Market Revenue Forecast by End-user

11.5.4. GCC

11.5.4.1. Market Revenue Forecast

11.5.5. North Africa

11.5.5.1. Market Revenue Forecast

11.5.6. South Africa

11.5.6.1. Market Revenue Forecast

11.5.7. Rest of MEA

11.5.7.1. Market Revenue Forecast

Chapter 12. Company Profiles

12.1. Zimmer Biomet

12.1.1. Company Overview, Business Information, Regional Presence

12.1.2. Product Portfolio Analysis

12.1.2.1. Product Details, Specification, Application

12.1.3. Revenue, Price, and Gross Margin

12.1.4. Recent Developments and Strategies

12.2. Arthrex, Inc.

12.2.1. Company Overview, Business Information, Regional Presence

12.2.2. Product Portfolio Analysis

12.2.2.1. Product Details, Specification, Application

12.2.3. Revenue, Price, and Gross Margin

12.2.4. Recent Developments and Strategies

12.3. Harvest Technologies Corporation

12.3.1. Company Overview, Business Information, Regional Presence

12.3.2. Product Portfolio Analysis

12.3.2.1. Product Details, Specification, Application

12.3.3. Revenue, Price, and Gross Margin

12.3.4. Recent Developments and Strategies

12.4. Stryker Corporation

12.4.1. Company Overview, Business Information, Regional Presence

12.4.2. Product Portfolio Analysis

12.4.2.1. Product Details, Specification, Application

12.4.3. Revenue, Price, and Gross Margin

12.4.4. Recent Developments and Strategies

12.5. DePuy Synthes, Inc.

12.5.1. Company Overview, Business Information, Regional Presence

12.5.2. Product Portfolio Analysis

12.5.2.1. Product Details, Specification, Application

12.5.3. Revenue, Price, and Gross Margin

12.5.4. Recent Developments and Strategies

12.6. Cesca Therapeutics, Inc.

12.6.1. Company Overview, Business Information, Regional Presence

12.6.2. Product Portfolio Analysis

12.6.2.1. Product Details, Specification, Application

12.6.3. Revenue, Price, and Gross Margin

12.6.4. Recent Developments and Strategies

12.7. AdiStem Ltd.

12.7.1. Company Overview, Business Information, Regional Presence

12.7.2. Product Portfolio Analysis

12.7.2.1. Product Details, Specification, Application

12.7.3. Revenue, Price, and Gross Margin

12.7.4. Recent Developments and Strategies

12.8. Exactech Inc.

12.8.1. Company Overview, Business Information, Regional Presence

12.8.2. Product Portfolio Analysis

12.8.2.1. Product Details, Specification, Application

12.8.3. Revenue, Price, and Gross Margin

12.8.4. Recent Developments and Strategies

12.9. ISTO Biologics

12.9.1. Company Overview, Business Information, Regional Presence

12.9.2. Product Portfolio Analysis

12.9.2.1. Product Details, Specification, Application

12.9.3. Revenue, Price, and Gross Margin

12.9.4. Recent Developments and Strategies

12.10. Nuo Therapeutics

12.10.1. Company Overview, Business Information, Regional Presence

12.10.2. Product Portfolio Analysis

12.10.2.1. Product Details, Specification, Application

12.10.3. Revenue, Price, and Gross Margin

12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global platelet rich plasma market size was reached at USD 834.74 million in 2024 and is anticipated to hit over USD 3,466.11 million by 2034.

Rising elderly population and intensifying orthopedic conditions are probable to lift the growth of global platelet rich plasma market. Research and Development in drug delivery system for platelet-rich bioactive molecules is anticipated to propose profitable development prospects for companies operational in the global platelet-rich plasma market.

The global platelet rich plasma market is growing at a CAGR of 15.30% between forecast period 2025 to 2034.

The Asia Pacific is anticipated to record the rapid growth during upcoming years.

Foremost participants operational in the global platelet-rich plasma market are, Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, CollPlant, Glofinn Oy, Johnson and Johnsons Ltd., Medira Ltd., Estar Technologies Ltd., Regen Lab S.A., Generex Biotechnology Corporation and others.

Platelet rich plasma signifies a comparatively novel method in regenerative medicine. It is extracted from patient’s blood and comprises numerous growth factors and other essential biomolecules for wound curing. As there are numerous protocols for PRP formulating, it typically results with PRP generation with diverse amounts of bioactive substances, which eventually modify the concentration of wound curing. also be utilized to advance healing after surgery for certain injuries.

Proceed To Buy

USD 4900
USD 3800
USD 1900
USD 1200
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us